Device Trial Radar · NCT05146336
CytOSorb TreatMent Of Critically Ill PatientS Registry
Last checked: Nov 19, 2026Latest source record: Oct 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
3,000
Planned (sponsor's estimate)
Start
Jun 22, 2022
Primary completion
Jun 2032
Study completion Sep 2032
Sponsor
- Lead sponsor
- CytoSorbents, IncNot on our public-company list
- Sponsor type
- Industry
- First posted
- Dec 6, 2021
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Registry intended to provide a data repository and reporting infrastructure for the surveillance of CytoSorb device use in real-world critical care settings, and to serve as an objective, comprehensive, and scientifically-based resource to measure and improve the quality of patient care
Conditions
- Septic Shock
- Acute Respiratory Distress Syndrome
- Trauma
- Rhabdomyolysis
- Cardiogenic Shock
- Pancreatitis
- Acute on Chronic Liver Failure
- Acute Liver Failure
- Burns
- Chimeric Antigen Receptor T-Cell Therapy (CAR-T) Cytokine Release Syndrome (CRS)
- Extracorporeal Life Support
- Postoperative Endocarditis
- Hemophagocytic Lymphohistiocytoses
- Liver Transplant; Complications
- Infectious Disease
- Postoperative Vasoplegic Syndrome
- Drug Overdose
- Sepsis
Interventions
CytoSorbDevice
Sorbent hemoperfusion system
Primary outcomes
What the sponsor says the trial is designed to measure.
- ICU mortalityTime frame: Through ICU discharge or date of death, whichever comes first [on average 7 days]
- In-hospital mortalityTime frame: Through hospital discharge or date of death, whichever comes first [on average 14 days]
Locations
28 sites in 6 countries. Site status is shown where the registry gives one.
Klinikum Klagenfurt am Wörthersee
Klagenfurt, Austria · Recruiting
Medizinische Universität Wien
Vienna, Austria · Recruiting
Universitätsklinikum Aachen
Aachen, Germany · Recruiting
25 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.